T he growth and hypertrophy of left ventricular myocardium in response to pressure or volume overload or segmental loss of functional myocardium was once considered a purely beneficial, structural adaptation to reduce or normalize systolic and/or diastolic wall stress. ' This concept has been challenged, however, by a growing body of evidence indicating that most forms of left ventricular hypertrophy (LVH) are associated with increased morbidity and mortality caused by progressive left ventricular contractile dysfunction, irreversible muscle injury, and the ultimate development of congestive heart failure. Thus, a rational approach to the patient with structural heart disease associated with LVH 
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Hemodynamic Overload and the Regulation of Myofibrillar Protein Degradation Allen M. Samarel, MD
T he growth and hypertrophy of left ventricular myocardium in response to pressure or volume overload or segmental loss of functional myocardium was once considered a purely beneficial, structural adaptation to reduce or normalize systolic and/or diastolic wall stress. ' This concept has been challenged, however, by a growing body of evidence indicating that most forms of left ventricular hypertrophy (LVH) are associated with increased morbidity and mortality caused by progressive left ventricular contractile dysfunction, irreversible muscle injury, and the ultimate development of congestive heart failure. Thus, a rational approach to the patient with structural heart disease associated with LVH Samarel, unpublished observations) . Thus, it is likely that mechanical activity, rather than electrical activity, in some way mediates the susceptibility of myofibrillar proteins to intracellular proteolysis in the absence of exogenous neural or humoral factors.
Although cellular "stretch" and active tension development affect myofibrillar protein degradative rates in these cell culture models, the manner in which mechanical deformation is converted into biochemical signals leading to altered proteolytic susceptibility remains unclear. In a recent review, Vandenburgh'0 outlined some of the putative "mechanogenic" second messengers involved in altering cell growth in a variety of mechanically sensitive cells, including striated muscle cells. These transducing pathways are of two general types: extracellular matrix (ECM)-integrin-cytoskeleton complexes and plasma membrane-associated molecules involved in the production of "diffusable" second messengers common to other receptor-mediated signal transduction pathways. These mechanical signals may be transduced directly by deformation activation of mechanosensitive catalysts or may be mediated by de 
